Clinical Trial Update: Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating medroxyprogesterone with or without cyclophosphamide and methotrexate in estrogen receptor-negative and progesterone receptor-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor Negative Breast Cancer
• Progesterone Receptor-negative Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• METHOTREXATE (METHOTREXATE)
• Medroxyprogesterone (medroxyprogesterone)

Snippet

Sponsor: Indiana University | Conditions: Estrogen Receptor-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-09-23